Literature DB >> 17787018

New implications for the QUAKING RNA binding protein in human disease.

Carol Anne Chénard1, Stéphane Richard.   

Abstract

The use of spontaneously occurring mouse models has proved to be a valuable tool throughout the years to delineate the signals required for nervous system development. This is especially true in the field of myelin biology, with a large number of different models available. The quaking viable mouse models dysmyelination in the nervous system and links the QUAKING RNA binding proteins to myelination and cell fate decisions. In this Mini-Review, we highlight the biological functions attributed to this KH-type RNA binding protein and the recent achievements linking it to human disorders. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17787018     DOI: 10.1002/jnr.21485

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  72 in total

1.  Temporal genomewide expression profiling of DSS colitis reveals novel inflammatory and angiogenesis genes similar to ulcerative colitis.

Authors:  Kai Fang; Megan Bruce; Christopher B Pattillo; Songlin Zhang; Randolph Stone; John Clifford; Christopher G Kevil
Journal:  Physiol Genomics       Date:  2010-10-05       Impact factor: 3.107

2.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder.

Authors:  Peter Holmans; Elaine K Green; Jaspreet Singh Pahwa; Manuel A R Ferreira; Shaun M Purcell; Pamela Sklar; Michael J Owen; Michael C O'Donovan; Nick Craddock
Journal:  Am J Hum Genet       Date:  2009-06-18       Impact factor: 11.025

3.  mir-35 is involved in intestine cell G1/S transition and germ cell proliferation in C. elegans.

Authors:  Min Liu; Pengpeng Liu; Li Zhang; Qingchun Cai; Ge Gao; Wenxia Zhang; Zuoyan Zhu; Dong Liu; Qichang Fan
Journal:  Cell Res       Date:  2011-06-21       Impact factor: 25.617

4.  Site identification in high-throughput RNA-protein interaction data.

Authors:  Philip J Uren; Emad Bahrami-Samani; Suzanne C Burns; Mei Qiao; Fedor V Karginov; Emily Hodges; Gregory J Hannon; Jeremy R Sanford; Luiz O F Penalva; Andrew D Smith
Journal:  Bioinformatics       Date:  2012-09-28       Impact factor: 6.937

5.  MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/β-catenin signaling by repressing the expression of Quaking proteins.

Authors:  Zhejia Zhang; Xinying Li; Qian Xiao; Zhiming Wang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

6.  Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation.

Authors:  Megan P Hall; Roland J Nagel; W Samuel Fagg; Lily Shiue; Melissa S Cline; Rhonda J Perriman; John Paul Donohue; Manuel Ares
Journal:  RNA       Date:  2013-03-22       Impact factor: 4.942

7.  The QKI-6 RNA binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte differentiation.

Authors:  Evgueni Doukhanine; Christina Gavino; Jeffery D Haines; Guillermina Almazan; Stéphane Richard
Journal:  Mol Biol Cell       Date:  2010-07-14       Impact factor: 4.138

8.  The QKI-6 RNA binding protein localizes with the MBP mRNAs in stress granules of glial cells.

Authors:  Yunling Wang; Geneviève Lacroix; Jeffery Haines; Evgueni Doukhanine; Guillermina Almazan; Stéphane Richard
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

9.  Sam68 regulates translation of target mRNAs in male germ cells, necessary for mouse spermatogenesis.

Authors:  Maria Paola Paronetto; Valeria Messina; Enrica Bianchi; Marco Barchi; Gillian Vogel; Costanzo Moretti; Fioretta Palombi; Mario Stefanini; Raffaele Geremia; Stéphane Richard; Claudio Sette
Journal:  J Cell Biol       Date:  2009-04-20       Impact factor: 10.539

10.  The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination.

Authors:  Daniel Larocque; Gabriela Fragoso; Jinghan Huang; Walter E Mushynski; Martin Loignon; Stéphane Richard; Guillermina Almazan
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.